EpiPen scandal is all about politics

Mylan Corp. has come under fire for raising the price of its life-saving EpiPen from $7 to $300 over the last nine years. A look at the political connections of Mylan CEO Heather Bresch reveals that the US government is marketing the EpiPen and stopping competitors from getting into the market.

Also: US allies in Syria are fighting each other, not ISIS; Turkey threatens the Kurds; US Army captain sues the President for declaring war without constitutional authority; New York Times accuses Russia of spreading propaganda (while spreading anti-Russian propaganda); clown tries to lure children into woods near Greenville, SC; and Sanhedrin appoints a new high priest in time for Yom Kippur.

UA-2941127-3